You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Monitoring Videos on Diabetes Health TV
Nipro Diabetes Systems Introduces The Amigo®
Diabetic Glucose Management & Paradigm Real Time
STAT™ Medical Devices
Popular A1c Test Articles
Highly Recommended A1c Test Articles
Infopia USA's Eocene System is a diabetes management system with a data collection device that gathers data from a meter, blood pressure cuff, and a thermal scale. Readings are stored on Infopia's network and available to you and your health team. See the video on Diabetes Health TV here.
0 comments - Jan 13, 2011 -
A full third of adult Americans are pre-diabetic, and a third of those will develop type 2 diabetes before they're ten years older. Unfortunately, only about seven percent of them have been tested for pre-diabetes and warned of their condition; the rest are ignorant of the road they're on. By losing just 10 to 15 pounds, the whole group could cut their chances of getting type 2 by half. The problem is, how to alert them in time for them to stop their progression to type 2?
7 comments - Jan 10, 2011 -
Sitagliptin (Januvia) has long been used to reduce blood sugar in people with type 2 diabetes, but a new study indicates that it can do the same for those with type 1 diabetes. Sitagliptin is a DPP-4 inhibitor; that is, it inhibits, or temporarily prevents, the enzyme DPP-4 from destroying a helpful hormone called GLP-1. GLP-1, which is released by the gut when food arrives there from the stomach, lowers blood sugar by causing the release of insulin, reducing the secretion of glucagon, and slowing stomach emptying and nutrient absorption.
3 comments - Jan 7, 2011 -
Arena Pharmaceuticals and Eisai Inc. recently released results of a phase 3 clinical trial for lorcaserin, a weight-loss drug they are developing in partnership. The trial, called BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management- Diabetes Management), targeted patients with type 2 diabetes who are overweight or obese.
2 comments - Dec 28, 2010 -
If you have type 1 diabetes, you know that the process of obtaining life insurance or long-term care insurance has been a long, tough road, most often leading to the dead end of declined coverage. In fact, most insurance companies have classified anyone with type 1 as an automatic decline, without any consideration of each case individually.
7 comments - Dec 14, 2010 -
0 comments - Dec 7, 2010 -
A new drug for type 2 diabetes started showing up in drugstores this week, according to manufacturer Santarus. The FDA-approved drug, called Cycloset, takes an distinctive -- and not well understood -- approach to reducing blood sugar levels. The pill apparently works by increasing dopamine activity in the hypothalamus, a part of the brain. Dopamine is a brain chemical that plays a big role in people's behavior, mood, and ability to sleep. Scientists theorize that glucose intolerance and insulin resistance may in part result from abnormal activity of this chemical, and that upping dopamine activity may iron out these problems.That's the theory, at least: the drug's exact workings aren't known. But it seems to do the trick.
0 comments - Nov 24, 2010 -
When I was diagnosed with type 1 diabetes 23 years ago, I remember being told that having children would be a very difficult challenge. I was seven years old at the time - still a child myself - and had no interest in becoming a mom. My own mother was very distressed at this news, but I didn't pay it any mind. I had other things to focus on: trees to climb, bikes to ride, and friends to play with.
1 comment - Nov 18, 2010 -
With just a few days left to 14 November, we imagine that a lot of you are making those final touches to your World Diabetes Day celebrations or have already started your awareness activities. Here's a further look at what will be taking place around the world to mark the day:
0 comments - Nov 6, 2010 -
Regular physical activity and exercise are recommended for the general population for overall improved health. However, exercise of moderate intensity increases the risk of hypoglycemia during and following exertion in those with type 1 diabetes mellitus (T1DM). Accordingly, exercise guidelines for T1DM focus on prevention of exercise-induced hypoglycemia.
1 comment - Oct 31, 2010 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.